{"query": "Dr Reddy's Labs shares slide 6% post Q3 results. Should you buy, sell, or hold?", "similar": [{"title": "India’s worst-performing stock in July may rebound if history is any guide", "date": "2021-07-30 12:09:00", "impact": "-13.06%"}, {"title": "Auto, pharma stocks offering margin of safety top funds’ buy list in July", "date": "2023-08-14 07:52:00", "impact": "+0.76%"}, {"title": "Dr Reddys Lab gains on deal with Citius Pharma for anti-cancer agent E7777", "date": "2021-09-06 09:21:00", "impact": "-0.57%"}]}
{"query": "Dr. Reddy’s Q3 & 9MFY25 Financial Results", "similar": [{"title": "BRIEF-India’s Dr.Reddy’s Laboratories Posts Dec-Qtr Consol Net Profit", "date": "2021-01-29 05:30:00", "impact": "-8.71%"}, {"title": "Beaten-down blue chips could be first to rebound", "date": "2022-03-21 05:48:00.000", "impact": "+7.06%"}, {"title": "BRIEF-Dr.Reddy’s Laboratories Takes Qtrly Impairment Charge Of 6.00 Bln Rupees", "date": "2021-01-29 05:30:00", "impact": "-8.71%"}]}
{"query": "Dr Reddy's shares tank 7% post Q3 results; should you buy, sell or hold?", "similar": [{"title": "India’s worst-performing stock in July may rebound if history is any guide", "date": "2021-07-30 12:09:00", "impact": "-13.06%"}, {"title": "Appetite increases for pharma stocks", "date": "2021-04-14 00:39:44.000", "impact": "+2.48%"}, {"title": "Auto, pharma stocks offering margin of safety top funds’ buy list in July", "date": "2023-08-14 07:52:00", "impact": "+0.76%"}]}
{"query": "Dr Reddy's Labs Q3 results: PAT rises 2.5% at Rs 1,413 cr, revenue up 16%", "similar": [{"title": "BRIEF-India’s Dr.Reddy’s Laboratories Posts Dec-Qtr Consol Net Profit", "date": "2021-01-29 05:30:00", "impact": "-8.71%"}, {"title": "TCS beats street estimates with 8.4% growth in profit", "date": "2022-10-10 18:19:00.000", "impact": "-0.90%"}, {"title": "Eris Lifesciences Acquires Nine Derma Brands From Dr Reddy’s For Rs 275 Crore", "date": "2023-03-16 15:14:43", "impact": "+1.40%"}]}
{"query": "Jefferies, Nuvama cut target price for Dr Reddy’s. 3 thing to know…", "similar": [{"title": "Tata Consumer zooms over 5% to hit 52-week high", "date": "2023-06-14 13:52:28.000", "impact": "+4.69%"}, {"title": "Nischal Maheshwari on 6 stock picks in pharma and IT", "date": "2023-07-05 11:35:00.000", "impact": "+0.44%"}, {"title": "Jefferies rejigs India model portfolio; Zomato, Bharti Airtel off menu", "date": "2022-12-20 22:07:14.000", "impact": "-0.79%"}]}
{"query": "Dr Reddy's Labs Q3 Results: Net profit up 2.5% at Rs 1,413 crore, beats estimate", "similar": [{"title": "BRIEF-India’s Dr.Reddy’s Laboratories Posts Dec-Qtr Consol Net Profit", "date": "2021-01-29 05:30:00", "impact": "-8.71%"}, {"title": "BRIEF-India’s Dr.Reddy’s Laboratories March-Quarter Consol Net Profit Falls", "date": "2021-05-14 05:30:00", "impact": "-3.40%"}, {"title": "Eris Lifesciences Acquires Nine Derma Brands From Dr Reddy’s For Rs 275 Crore", "date": "2023-03-16 15:14:43", "impact": "+1.40%"}]}
{"query": "Explained: Why Dr Reddy's share price cracked 6% in early trade", "similar": [{"title": "Tata Consumer hits 52-week high on upcoming entry into Nifty50 club", "date": "2021-02-24 12:01:21.000", "impact": "-5.98%"}, {"title": "Risk-reward ratio is favourable in select pharma companies: CLSA", "date": "2022-02-24 06:28:00", "impact": "-4.56%"}, {"title": "Dr Reddys Lab gains on deal with Citius Pharma for anti-cancer agent E7777", "date": "2021-09-06 09:21:00", "impact": "-0.57%"}]}
{"query": "Dr Reddy's Labs Q3 Results: Cons PAT rises 2% YoY to Rs 1,413 crore, revenue up 16%", "similar": [{"title": "BRIEF-India’s Dr.Reddy’s Laboratories Posts Dec-Qtr Consol Net Profit", "date": "2021-01-29 05:30:00", "impact": "-8.71%"}, {"title": "TCS beats street estimates with 8.4% growth in profit", "date": "2022-10-10 18:19:00.000", "impact": "-0.90%"}, {"title": "Eris Lifesciences Acquires Nine Derma Brands From Dr Reddy’s For Rs 275 Crore", "date": "2023-03-16 15:14:43", "impact": "+1.40%"}]}
{"query": "Dr Reddy's Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth", "similar": [{"title": "Cement companies likely to focus on volume growth next fiscal amid higher competition and volatile input costs", "date": "2022-12-28 06:28:00.000", "impact": "-2.18%"}, {"title": "BRIEF-India’s Dr.Reddy’s Laboratories Posts Dec-Qtr Consol Net Profit", "date": "2021-01-29 05:30:00", "impact": "-8.71%"}, {"title": "Sun Pharma: Steady growth, but higher valuation", "date": "2023-08-04 09:46:50.000", "impact": "+1.16%"}]}
